ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
6,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
7,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
10,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
12,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
12,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
14,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
15,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
16,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
17,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
18,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
19,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
20,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
21,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
21,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
22,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
23,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
23,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
24,2,Headache,Headaches NEC,Headaches,Nerv,N
25,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
26,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
27,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
28,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
29,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
29,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
30,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
31,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
32,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
33,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
33,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
33,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
34,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
34,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
34,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
35,1,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
35,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
35,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
36,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
36,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
37,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
37,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
37,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
37,4,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
37,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
37,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
37,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
38,2,Nail bed tenderness,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
39,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
39,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
40,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
40,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
41,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
43,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
43,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
43,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
43,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
44,1,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
44,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
44,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
44,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
45,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
45,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
46,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
46,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
47,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
47,2,Application site papules,Application site reactions,Administration site reactions,Genrl,N
47,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
47,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
47,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
47,6,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
48,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
48,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
48,3,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
49,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
49,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
49,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
50,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
50,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
50,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
51,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
51,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
52,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
52,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
53,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
54,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
54,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
54,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
54,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
54,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
55,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
56,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
57,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
58,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
59,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
59,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
59,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
60,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
60,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
61,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
62,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
62,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
62,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
62,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
62,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
63,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
64,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
64,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
64,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
64,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
65,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
65,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
66,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
66,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
67,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
67,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
67,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
69,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
70,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
70,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
70,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
71,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
71,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
72,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
72,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
72,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
72,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
72,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
72,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
72,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
72,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
72,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
72,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,13,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
72,14,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
73,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
73,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Aesthesioneuroblastoma,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
74,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
75,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
76,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
77,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
77,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
77,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
78,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
79,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,2,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
79,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
79,4,Tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
79,5,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
80,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
81,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
81,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
82,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
83,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
83,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
84,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
84,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
85,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
86,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
87,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
87,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
87,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
87,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
88,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
88,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
88,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
88,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
89,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
90,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
91,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,2,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
93,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
94,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
94,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
95,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
95,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
95,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
95,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
96,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
96,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
96,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
97,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
97,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
97,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
98,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
99,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
99,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
99,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
100,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
100,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
100,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
101,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
101,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
101,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
101,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
101,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
101,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
101,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,10,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
103,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
104,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
104,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
105,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
105,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
105,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
106,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
106,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
107,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
107,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
108,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
110,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
111,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
111,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
112,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
113,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
113,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
113,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
113,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
114,4,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
115,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
115,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
116,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
116,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
118,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
119,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
119,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
119,3,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
120,1,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
120,2,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
120,3,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
120,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
121,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
121,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
121,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
121,4,Application site paraesthesia,Application site reactions,Administration site reactions,Genrl,N
121,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
122,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
123,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
124,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
124,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
124,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
125,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
125,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
125,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
126,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
126,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
127,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
129,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
131,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
131,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
131,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
132,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
133,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
133,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
133,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
134,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
134,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
134,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
134,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
135,1,Headache,Headaches NEC,Headaches,Nerv,N
135,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
135,3,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
136,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
137,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
137,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
138,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
139,1,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
140,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
140,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
140,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
142,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
142,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
142,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
143,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
143,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
143,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
143,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
143,5,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
144,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
144,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
144,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
145,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
145,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
145,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
145,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
145,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
145,7,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
145,8,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
145,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
145,10,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
145,11,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
145,12,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
145,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
145,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
145,15,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
145,16,Stasis dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
146,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
147,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
148,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
149,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
149,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
149,3,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
